1497 related articles for article (PubMed ID: 33711754)
1. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
3. Racial Disparities in the Risk for Thromboembolic Events in COVID-19 Patients during the Height of the SARS-CoV-2 Pandemic and Impact on Outcomes.
Nam J; D'Andrea M; O'Hara A; Staszewski L; Pozin J; Wozniak A; Korepta L; Halandras P; Soult M; Aulivola B
Ann Vasc Surg; 2022 Nov; 87():278-285. PubMed ID: 35589032
[TBL] [Abstract][Full Text] [Related]
4. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study.
Burn E; Duarte-Salles T; Fernandez-Bertolin S; Reyes C; Kostka K; Delmestri A; Rijnbeek P; Verhamme K; Prieto-Alhambra D
Lancet Infect Dis; 2022 Aug; 22(8):1142-1152. PubMed ID: 35576963
[TBL] [Abstract][Full Text] [Related]
5. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients.
Othman HY; Zaki IAH; Isa MR; Ming LC; Zulkifly HH
BMC Infect Dis; 2024 May; 24(1):484. PubMed ID: 38730292
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.
Maximiano Sousa F; Roelens M; Fricker B; Thiabaud A; Iten A; Cusini A; Flury D; Buettcher M; Zukol F; Balmelli C; Zimmermann P; Troillet N; Vuichard-Gysin D; Schreiber PW; Bernhard-Stirnemann S; Tschudin-Sutter S; Nussbaumer-Ochsner Y; Sommerstein R; Gaudenz R; Marschall J; Senn L; Gardiol C; Keiser O; Schüpbach G; Wymann M; Vidondo B; Ch-Sur Study Group
Swiss Med Wkly; 2021 Jul; 151():w20547. PubMed ID: 34324698
[TBL] [Abstract][Full Text] [Related]
8. Thrombo-inflammatory response in hospitalised patients with COVID-19: a single institution experience.
Sultan MA; Kong Y; Story C; Caterson H; Dix C; Gad F; Dhaliwal JS; Dunkley S; Jo H; van Hal S; Passam F
Intern Med J; 2024 Jan; 54(1):43-53. PubMed ID: 37926861
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary embolism in cases of COVID-19.
Tveita A; Hestenes S; Sporastøyl ER; Pettersen SA; Neple BL; Myrstad M; Tveit A; Frøen H; Svendsen J; Rønning EJ
Tidsskr Nor Laegeforen; 2020 May; 140(8):. PubMed ID: 32463186
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
[TBL] [Abstract][Full Text] [Related]
11. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
[TBL] [Abstract][Full Text] [Related]
12. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of people living with HIV hospitalised at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City.
Caro-Vega Y; Guerrero-Torres L; Cárdenas-Ortega A; Martin-Onraët A; Rodríguez-Zulueta P; Romero-Mora K; Schjetnan MG; Piñeirúa-Menéndez A
BMC Infect Dis; 2024 May; 24(1):524. PubMed ID: 38789972
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19.
Lu YF; Pan LY; Zhang WW; Cheng F; Hu SS; Zhang X; Jiang HY
Int J Infect Dis; 2020 Nov; 100():34-41. PubMed ID: 32798659
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Analysis of In-Hospital Mortality per Disease Groups in Germany Before and During the COVID-19 Pandemic From 2016 to 2020.
König S; Pellissier V; Hohenstein S; Leiner J; Hindricks G; Meier-Hellmann A; Kuhlen R; Bollmann A
JAMA Netw Open; 2022 Feb; 5(2):e2148649. PubMed ID: 35166779
[TBL] [Abstract][Full Text] [Related]
18. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis.
Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.
Piroth L; Cottenet J; Mariet AS; Bonniaud P; Blot M; Tubert-Bitter P; Quantin C
Lancet Respir Med; 2021 Mar; 9(3):251-259. PubMed ID: 33341155
[TBL] [Abstract][Full Text] [Related]
20. Risks and burdens of incident dyslipidaemia in long COVID: a cohort study.
Xu E; Xie Y; Al-Aly Z
Lancet Diabetes Endocrinol; 2023 Feb; 11(2):120-128. PubMed ID: 36623520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
